Hormone Release and Stomach Disturbances in People With Binge Eating Disorder
Postprandial Cholecystokinin Release and Gastric Emptying in Binge Eating Disorder
3 other identifiers
observational
24
1 country
1
Brief Summary
This study will determine whether the disturbances in cholecystokinin release and gastric emptying that occur in people with binge eating disorder are similar to those that occur in people with bulimia nervosa.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2004
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2004
CompletedFirst Submitted
Initial submission to the registry
March 23, 2006
CompletedFirst Posted
Study publicly available on registry
March 27, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2009
CompletedMay 28, 2012
May 1, 2012
5 years
March 23, 2006
May 25, 2012
Conditions
Keywords
Study Arms (2)
Binge Eating Disorder
Women with Binge Eating Disorder
Controls
Weight, age, and gender-matched control subjects
Eligibility Criteria
Healthy, obese women between ages 18 and 60 with and without Binge Eating Disorder
You may qualify if:
- For all participants:
- Obese (body mass index (BMI) greater than 35 kg/m2)
- For participants with BED:
- Meets DSM-IV criteria for BED
- BED duration of at least 1 year
- For healthy participants:
- Weight close to that of participants with BED
You may not qualify if:
- Current or past diagnosis of BN, or any binge eating or self-induced vomiting
- Significant medical illness
- Current or lifetime history of schizophrenia, bipolar disorder, or other psychotic disorder as defined by DSM-IV-TR
- Current DSM-IV-TR diagnosis of organic mental disorder, factitious disorder, or malingering
- History of a personality disorder (e.g., schizotypal, borderline, or antisocial) that might interfere with assessment or compliance with the study procedures
- At risk for suicide
- Currently taking psychotropic medication or medication that is known to affect appetite or gastric functioning
- History of drug or alcohol abuse within the 3 months prior to study entry
- Pregnant, planning to become pregnant, or lactating
- Anemia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eating Disorders Clinic, New York State Psychiatric Institute
New York, New York, 10032, United States
Biospecimen
Blood serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
B. T. Walsh, MD
New York State Psychiatric Institute at Columbia University Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 23, 2006
First Posted
March 27, 2006
Study Start
October 1, 2004
Primary Completion
October 1, 2009
Study Completion
October 1, 2009
Last Updated
May 28, 2012
Record last verified: 2012-05